Posted on 7/28/20
Karuna Therapeutics and PsychoGenics Announce Drug Discovery Collaboration
BOSTON & PARAMUS, N.J.--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives . . .
Posted on 7/28/20
Thermo Fisher: A Strong First Semester Doesn't Mean It's Cheap
SummaryThermo Fisher's share price has increased by more than 60% since the March lows.Despite a good free cash flow result in H1, the valuation is perhaps . . .
Posted on 7/28/20
Pfizer Reports Second-Quarter 2020 Results
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) reported financial results for second-quarter 2020, increased its 2020 financial guidance for revenues and Adjusted diluted EPS(3) and reaffirmed all . . .
Posted on 7/28/20
Vertex Pharmaceuticals For A Strong Portfolio
SummaryVertex Pharmaceuticals owns a blockbuster drug, TRIKAFTA, which treats cystic fibrosis (CF). The company currently commands a monopoly in treating CF.It is armed with a cash . . .
Posted on 7/28/20
The CVS-Aetna Acqusition Is Showing Results
SummaryIn 2018 CVS purchases Aetna for $78 Billion.I previously analyzed the S-4 put out by CVS to see what a combined company would look like.The results . . .
Posted on 7/28/20
Moderna Starts Phase 3 Clinical Trial of Its Coronavirus Vaccine Candidate
One of the most eagerly anticipated clinical trials of our time has begun. Moderna (NASDAQ:MRNA) announced Monday that it has started inoculating patients in the phase . . .
Posted on 7/27/20
TCR Therapeutics Proposes Public Offering of Common Stock
CAMBRIDGE, Mass., July 27, 2020 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company with a pipeline of novel T cell therapies for . . .
Posted on 7/27/20
BioXcel Therapeutics Proposes Public Offering of Common Stock
NEW HAVEN, Conn., July 27, 2020 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a clinical-stage biopharmaceutical development company, today announced that it has commenced an underwritten . . .
Posted on 7/27/20
Bay Copy Works with Signature Healthcare to Provide Major Upgrade to their Document Generation
Bay Copy, a leading provider of digital document solutions, has entered into a five-year agreement with Signature Healthcare an integrated healthcare organization that owns Brockton Hospital, . . .
Posted on 7/27/20
Cerevel Therapeutics and Cyclica Announce Research Collaboration
BOSTON & TORONTO--(BUSINESS WIRE)--Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, and Cyclica, whose AI-augmented, integrated platform enables . . .
Posted on 7/27/20
AMAG Pharmaceuticals Completes Divestment of Women’s Health Assets
WALTHAM, Mass., July 27, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced AMAG and Palatin Technologies, Inc. have mutually terminated the January 2017 . . .
Posted on 7/27/20
IPO Update: AlloVir Proposes Terms For $251 Million IPO
SummaryAlloVir intends to raise $251 million in a U.S. IPO of its common stock.The firm is developing treatments for various virus-associated conditions, including Covid19.While the IPO . . .
Posted on 7/27/20
Why iRobot Stock Is Down
In this episode of MarketFoolery, Chris Hill chats with Motley Fool analyst Abi Malin about the latest earnings reports and news from Wall Street. They discuss . . .
Posted on 7/27/20
Boston Beer Earnings Double; Shares Soar
Boston Beer Company (NYSE:SAM), maker of Samuel Adams beer, Angry Orchard Hard Cider, and Truly Hard Seltzer, reported second-quarter results that had the share price up . . .
Posted on 7/27/20
Dunkin’ Creates an Executive Position to Improve Digital Operations
As Dunkin' Brands Group (NASDAQ:DNKN) moves to cut back on its older, lower-volume locations while opening more of its NextGen restaurants, the company also recognizes the . . .
Posted on 7/27/20
Here's Why Biogen Just Blew Its Q2 Earnings Out of the Water
Biogen (NASDAQ:BIIB) saw its stock jumped after the company released its second-quarter results on Thursday. The biotech beat analysts' earnings estimates for the fifth consecutive quarter . . .
Posted on 7/27/20
Is Moderna Stock a Buy?
All eyes are on the drug manufacturers that are racing to develop the first safe and efficacious coronavirus vaccine. Global COVID-19 cases have crossed the 15 . . .
Posted on 7/26/20
iTeos Therapeutics Prices IPO
CAMBRIDGE, Mass. and GOSSELIES, Belgium, July 23, 2020 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of . . .
Posted on 7/26/20
Inozyme Pharma Prices IPO
BOSTON, July 23, 2020 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal . . .
Posted on 7/24/20
Vynamic Announces Partnership with Innovations in Healthcare
Vynamic, a global healthcare industry management consulting firm, and Innovations in Healthcare have created a unique partnership to source, strengthen, study, and scale promising innovations across . . .
Posted on 7/23/20
Ovid Therapeutics and University of Connecticut Enter into Strategic Research Collaboration
NEW YORK and FARMINGTON, Conn., July 23, 2020 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the . . .
Posted on 7/23/20
AMAG Pharmaceuticals and Norgine B.V. Enter Into Exclusive Licensing Agreement
WALTHAM, Mass. and AMSTERDAM, The Netherlands, July 23, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) and Norgine B.V., a leading European specialist pharmaceutical company, . . .
Posted on 7/23/20
G1 Therapeutics Announces License Agreement for Lerociclib
RESEARCH TRIANGLE PARK, N.C. and CAMBRIDGE, Mass., July 22, 2020 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced a license . . .
Posted on 7/23/20
Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant
The Menarini Group and Radius Health, Inc. (Nasdaq: RDUS) announced today that the companies have entered into an exclusive global license agreement for development and commercialization . . .
Posted on 7/23/20
Current Health Partners with Dexcom
BOSTON--(BUSINESS WIRE)--Current Health today announced it has partnered with Dexcom to add continuous glucose monitoring (CGM) capabilities to Current Health’s AI-powered remote patient monitoring (RPM) platform. . . .
Boston
